Model
Edge
EyePoint Pharmaceuticals Inc.
0001652285
Filing type
4
Filing date
Sep 5, 2023
Updated
Sep 6, 2023 ยท 11:14 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership